Endoscopic Ultrasound-guided Radiofrequency Ablation Versus Surgical Resection for Treatment of Pancreatic Insulinoma
The risks of microdosing are significant and multifaceted: Therapeutic inefficacy : Sub-therapeutic doses may fail to achieve meaningful improvements in glycaemic control or weight management, potentially delaying appropriate treatment and allowing disease progression
Significant fat reduction and substantial weight loss takes time to occur with semaglutide
Most people return to their pre-illness weight trajectory within 2-3 weeks as inflammation resolves and normal routines resume
The GLP-1 system works through continuous receptor signaling, not dose accumulation, so a single extra injection won't 'catch you up' on weight loss from the missed week
It tells your pancreas to release insulin to manage blood sugar, it blocks the release of glucagon (which raises blood sugar), andcrucially for weight lossit sends powerful satiety signals to your brain and slows down gastric emptying
